• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

平行进口与强制替代改革:对药品价格竞争是助力还是阻碍?

Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals?

作者信息

Granlund David, Koksal-Ayhan Miyase Yesim

机构信息

HUI Research, SE-103 29, Stockholm, Sweden.

Department of Economics, Umeå University, SE-901 87, Umeå, Sweden.

出版信息

Eur J Health Econ. 2015 Dec;16(9):969-83. doi: 10.1007/s10198-014-0646-9. Epub 2014 Nov 18.

DOI:10.1007/s10198-014-0646-9
PMID:25404013
Abstract

What has been the effect of competition from parallel imports on prices of locally sourced on-patent drugs? Did the 2002 Swedish mandatory substitution reform increase this competition? To answer these questions, we carried out difference-in-differences estimation on monthly data for a panel of all locally sourced on-patent prescription drugs sold in Sweden during the 40 months from January 2001 to April 2004. On average, facing competition from parallel imports caused a 15-17% fall in price. While the reform increased the effect of competition from parallel imports, it was only by 0.9%. The reform, however, did increase the effect of therapeutic competition by 1.6%.

摘要

平行进口带来的竞争对本地采购的专利药品价格产生了怎样的影响?2002年瑞典的强制替代改革是否加剧了这种竞争?为回答这些问题,我们对2001年1月至2004年4月这40个月内在瑞典销售的所有本地采购专利处方药面板的月度数据进行了双重差分估计。平均而言,面临平行进口的竞争导致价格下降了15%至17%。虽然改革增强了平行进口带来的竞争效应,但增幅仅为0.9%。不过,改革确实使治疗性竞争的效应提高了1.6%。

相似文献

1
Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals?平行进口与强制替代改革:对药品价格竞争是助力还是阻碍?
Eur J Health Econ. 2015 Dec;16(9):969-83. doi: 10.1007/s10198-014-0646-9. Epub 2014 Nov 18.
2
Parallel imports and the pricing of pharmaceutical products: evidence from the European Union.药品的平行进口与定价:来自欧盟的证据
J Health Econ. 2004 Sep;23(5):1035-57. doi: 10.1016/j.jhealeco.2004.03.005.
3
Price and welfare effects of a pharmaceutical substitution reform.药品替代改革的价格和福利效应。
J Health Econ. 2010 Dec;29(6):856-65. doi: 10.1016/j.jhealeco.2010.08.003. Epub 2010 Aug 19.
4
Price competition in pharmaceuticals - Evidence from 1303 Swedish markets.药品价格竞争 - 来自 1303 个瑞典市场的证据。
J Health Econ. 2018 Sep;61:1-12. doi: 10.1016/j.jhealeco.2018.06.009. Epub 2018 Jun 30.
5
Do follow-on therapeutic substitutes induce price competition between hospital medicines? Evidence from the Danish hospital sector.后续治疗替代药物是否会引发医院药品之间的价格竞争?来自丹麦医院部门的证据。
Health Policy. 2013 Jun;111(1):68-77. doi: 10.1016/j.healthpol.2013.03.007. Epub 2013 Apr 12.
6
Pharmaceuticals and Medical Devices: Cost Savings.药品和医疗器械:成本节约。
Issue Brief Health Policy Track Serv. 2017 Dec 26;2017:1-31.
7
Endogenous versus exogenous generic reference pricing for pharmaceuticals.药品的内源性与外源性仿制药参考定价
Int J Health Econ Manag. 2017 Dec;17(4):413-432. doi: 10.1007/s10754-017-9216-x. Epub 2017 May 15.
8
Parallel imports under a manufacturer rebate and a price freeze: Evidence from Germany.制造商回扣与价格冻结下的平行进口:来自德国的证据。
Health Econ. 2023 Feb;32(2):302-323. doi: 10.1002/hec.4621. Epub 2022 Nov 6.
9
Parallel trade of pharmaceuticals: The Danish market for statins.药品平行贸易:丹麦的他汀类药物市场。
Health Econ. 2018 Feb;27(2):333-356. doi: 10.1002/hec.3551. Epub 2017 Sep 4.
10
Regulation of pharmaceutical prices: evidence from a reference price reform in Denmark.药品价格监管:来自丹麦参考价格改革的证据
J Health Econ. 2014 Jul;36:174-87. doi: 10.1016/j.jhealeco.2014.04.003. Epub 2014 May 9.

引用本文的文献

1
Cambodia's Imminent Graduation from Least Developed Country Status: What Will be the Impact of the TRIPS Agreement on Access to HIV and Hepatitis C Medicines in Cambodia?柬埔寨即将脱离最不发达国家地位:TRIPS 协议对柬埔寨获得艾滋病毒和丙型肝炎药物的影响是什么?
Int J Soc Determinants Health Health Serv. 2024 Jul;54(3):295-308. doi: 10.1177/27551938241242602. Epub 2024 Apr 2.
2
The pan-Canadian Tiered Pricing Framework and Chinese National Volume-Based Procurement: A comparative study using Donabedian's structure-process-outcome framework.泛加分层定价框架与中国国家基于量的采购:运用 Donabedian 的结构-过程-结果框架进行的比较研究。
J Glob Health. 2023 Nov 10;13:04137. doi: 10.7189/jogh.13.04137.
3

本文引用的文献

1
The welfare impact of parallel imports: a structural approach applied to the German market for oral anti-diabetics.平行进口的福利影响:一种应用于德国口服抗糖尿病药物市场的结构方法。
Health Econ. 2014 Sep;23(9):1036-57. doi: 10.1002/hec.3068.
2
Regulation of pharmaceutical prices: evidence from a reference price reform in Denmark.药品价格监管:来自丹麦参考价格改革的证据
J Health Econ. 2014 Jul;36:174-87. doi: 10.1016/j.jhealeco.2014.04.003. Epub 2014 May 9.
3
Effects of reference pricing in pharmaceutical markets: a review.药品市场参考定价的影响:综述
What is the impact of intellectual property rules on access to medicines? A systematic review.
知识产权规则对药品可及性有何影响?一项系统综述。
Global Health. 2022 Apr 15;18(1):40. doi: 10.1186/s12992-022-00826-4.
4
Reforming the Swedish pharmaceuticals market: consequences for costs per defined daily dose.瑞典药品市场改革:每限定日剂量成本的影响
Int J Health Econ Manag. 2016 Sep;16(3):201-214. doi: 10.1007/s10754-016-9186-4. Epub 2016 Feb 8.
Pharmacoeconomics. 2011 Jan;29(1):17-33. doi: 10.2165/11537860-000000000-00000.
4
Price and welfare effects of a pharmaceutical substitution reform.药品替代改革的价格和福利效应。
J Health Econ. 2010 Dec;29(6):856-65. doi: 10.1016/j.jhealeco.2010.08.003. Epub 2010 Aug 19.
5
Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals?私人医生是否更有可能否决处方药的通用名替换?
Soc Sci Med. 2009 Dec;69(11):1643-50. doi: 10.1016/j.socscimed.2009.09.016. Epub 2009 Oct 6.
6
Reference pricing and firms' pricing strategies.参考定价与企业定价策略。
J Health Econ. 2009 Jan;28(1):176-97. doi: 10.1016/j.jhealeco.2008.09.006. Epub 2008 Oct 4.
7
The impact of generic reference pricing interventions in the statin market.仿制药参考定价干预措施对他汀类药物市场的影响。
Health Policy. 2007 Nov;84(1):14-29. doi: 10.1016/j.healthpol.2007.02.010. Epub 2007 Mar 26.
8
Reference pricing of pharmaceuticals.药品参考定价
J Health Econ. 2007 May 1;26(3):613-42. doi: 10.1016/j.jhealeco.2006.11.003. Epub 2006 Dec 22.
9
Reimbursement and clinical guidance for pharmaceuticals in Sweden: do health-economic evaluations support decision making?瑞典药品的报销与临床指南:卫生经济评估是否支持决策制定?
Eur J Health Econ. 2005 Sep;6(3):274-9. doi: 10.1007/s10198-005-0301-6.
10
Pricing and welfare implications of parallel imports in the pharmaceutical industry.制药行业平行进口的定价与福利影响
Int J Health Care Finance Econ. 2005 Mar;5(1):5-21. doi: 10.1007/s10754-005-6599-x.